RXST Financial Statements

Balance sheet, income statement, cash flow, and dividends for Rxsight Inc (RXST).


$1.39B Market Cap.

As of 02/26/2025 5:00 PM ET (MRY) • Disclaimer

RXST Market Cap. (MRY)


RXST Shares Outstanding (MRY)


RXST Assets (MRY)


Total Assets

$318.56M

Total Liabilities

$37.33M

Total Investments

$220.52M

RXST Income (MRY)


Revenue

$139.93M

Net Income

-$27.45M

Operating Expense

$135.80M

RXST Cash Flow (MRY)


CF Operations

-$16.95M

CF Investing

-$99.31M

CF Financing

$123.32M

RXST Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

RXST Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$318,563,000 (74.51%)

$182,550,000 (21.57%)

$150,164,000 (-22.08%)

$192,721,000 (91.43%)

Assets Current

$293,823,000 (74.47%)

$168,407,000 (25.16%)

$134,555,000 (-23.68%)

$176,295,000 (116.31%)

Assets Non-Current

$24,740,000 (74.93%)

$14,143,000 (-9.39%)

$15,609,000 (-4.97%)

$16,426,000 (-14.35%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$281,238,000 (75.38%)

$160,362,000 (78.37%)

$89,902,000 (-34.97%)

$138,242,000 (132.11%)

Property Plant & Equipment Net

$23,630,000 (77.87%)

$13,285,000 (-5.65%)

$14,081,000 (-9.16%)

$15,501,000 (-16.69%)

Cash & Equivalents

$17,456,000 (67.80%)

$10,403,000 (-17.40%)

$12,595,000 (-49.96%)

$25,172,000 (74.14%)

Accumulated Other Comprehensive Income

$166,000 (3420.00%)

-$5,000 (94.74%)

-$95,000 (-375.00%)

-$20,000 (-566.67%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$220,517,000 (87.69%)

$117,490,000 (25.03%)

$93,968,000 (-30.38%)

$134,971,000 (145.49%)

Investments Current

$220,517,000 (87.69%)

$117,490,000 (25.03%)

$93,968,000 (-30.38%)

$134,971,000 (145.49%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$22,009,000 (26.34%)

$17,421,000 (17.43%)

$14,835,000 (84.70%)

$8,032,000 (-3.09%)

Trade & Non-Trade Receivables

$30,050,000 (48.17%)

$20,281,000 (85.11%)

$10,956,000 (125.34%)

$4,862,000 (69.70%)

Trade & Non-Trade Payables

$4,544,000 (17.63%)

$3,863,000 (48.86%)

$2,595,000 (53.64%)

$1,689,000 (48.94%)

Accumulated Retained Earnings (Deficit)

-$622,095,000 (-4.62%)

-$594,640,000 (-8.90%)

-$546,032,000 (-13.93%)

-$479,276,000 (-11.31%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$12,296,000 (308.23%)

$3,012,000 (-93.31%)

$44,995,000 (0.14%)

$44,931,000 (46.11%)

Debt Current

$974,000 (-45.92%)

$1,801,000 (-8.58%)

$1,970,000 (28.84%)

$1,529,000 (20.02%)

Debt Non-Current

$11,322,000 (834.93%)

$1,211,000 (-97.19%)

$43,025,000 (-0.87%)

$43,402,000 (47.24%)

Total Liabilities

$37,325,000 (68.22%)

$22,188,000 (-63.18%)

$60,262,000 (10.62%)

$54,479,000 (21.32%)

Liabilities Current

$25,876,000 (23.79%)

$20,903,000 (21.27%)

$17,237,000 (55.61%)

$11,077,000 (-4.51%)

Liabilities Non-Current

$11,449,000 (790.97%)

$1,285,000 (-97.01%)

$43,025,000 (-0.87%)

$43,402,000 (30.31%)

RXST Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$139,927,000 (57.09%)

$89,077,000 (81.77%)

$49,005,000 (116.90%)

$22,593,000 (53.92%)

Cost of Revenue

$40,984,000 (16.06%)

$35,312,000 (27.59%)

$27,677,000 (53.11%)

$18,076,000 (39.34%)

Selling General & Administrative Expense

$101,434,000 (35.61%)

$74,799,000 (27.50%)

$58,665,000 (78.83%)

$32,805,000 (116.16%)

Research & Development Expense

$34,367,000 (18.30%)

$29,051,000 (11.82%)

$25,981,000 (6.05%)

$24,499,000 (11.69%)

Operating Expenses

$135,801,000 (30.77%)

$103,850,000 (22.69%)

$84,646,000 (47.71%)

$57,304,000 (54.39%)

Interest Expense

$21,000 (-99.37%)

$3,308,000 (-33.12%)

$4,946,000 (34.33%)

$3,682,000 (621.96%)

Income Tax Expense

$50,000 (150.00%)

$20,000 (122.22%)

$9,000 (12.50%)

$8,000 (-85.96%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$27,455,000 (43.52%)

-$48,608,000 (27.19%)

-$66,756,000 (-37.11%)

-$48,688,000 (-276.57%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$27,455,000 (43.52%)

-$48,608,000 (27.19%)

-$66,756,000 (-37.11%)

-$48,688,000 (-276.57%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$27,455,000 (43.52%)

-$48,608,000 (27.19%)

-$66,756,000 (-37.11%)

-$48,688,000 (-1546.46%)

Weighted Average Shares

$38,867,726 (12.81%)

$34,455,111 (24.56%)

$27,661,982 (103.02%)

$13,625,044 (267.53%)

Weighted Average Shares Diluted

$38,867,726 (12.81%)

$34,455,111 (24.56%)

$27,661,982 (103.02%)

$13,625,044 (146.28%)

Earning Before Interest & Taxes (EBIT)

-$27,384,000 (39.52%)

-$45,280,000 (26.73%)

-$61,801,000 (-37.34%)

-$44,998,000 (-259.90%)

Gross Profit

$98,943,000 (84.03%)

$53,765,000 (152.09%)

$21,328,000 (372.17%)

$4,517,000 (164.93%)

Operating Income

-$36,858,000 (26.41%)

-$50,085,000 (20.90%)

-$63,318,000 (-19.95%)

-$52,787,000 (-49.07%)

RXST Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$99,311,000 (-348.78%)

-$22,129,000 (-155.39%)

$39,950,000 (148.77%)

-$81,907,000 (-625.35%)

Net Cash Flow from Financing

$123,319,000 (100.44%)

$61,524,000 (871.64%)

$6,332,000 (-95.39%)

$137,342,000 (444.21%)

Net Cash Flow from Operations

-$16,946,000 (59.26%)

-$41,593,000 (29.32%)

-$58,850,000 (-31.63%)

-$44,708,000 (-27.00%)

Net Cash Flow / Change in Cash & Cash Equivalents

$7,053,000 (421.76%)

-$2,192,000 (82.57%)

-$12,577,000 (-217.36%)

$10,717,000 (90.52%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$93,871,000 (-442.14%)

-$17,315,000 (-140.89%)

$42,343,000 (152.95%)

-$79,967,000 (-541.15%)

Capital Expenditure

-$5,440,000 (-13.00%)

-$4,814,000 (-101.17%)

-$2,393,000 (-23.35%)

-$1,940,000 (23.50%)

Issuance (Repayment) of Debt Securities

-$61,000 (99.86%)

-$42,388,000 (-15835.34%)

-$266,000 (-101.79%)

$14,841,000 (-38.60%)

Issuance (Purchase) of Equity Shares

$128,916,000 (21.67%)

$105,957,000 (1253.56%)

$7,828,000 (-93.54%)

$121,136,000 (12111.29%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$9,000 (-250.00%)

$6,000 (166.67%)

-$9,000 (10.00%)

-$10,000 (0%)

Share Based Compensation

$24,635,000 (56.45%)

$15,746,000 (38.16%)

$11,397,000 (50.46%)

$7,575,000 (81.00%)

Depreciation Amortization & Accretion

$3,624,000 (-14.59%)

$4,243,000 (5.49%)

$4,022,000 (0.85%)

$3,988,000 (-0.60%)

RXST Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

70.70% (17.05%)

60.40% (38.85%)

43.50% (117.50%)

20.00% (72.41%)

Profit Margin

-19.60% (64.10%)

-54.60% (59.91%)

-136.20% (36.80%)

-215.50% (-1041.05%)

EBITDA Margin

-17.00% (63.12%)

-46.10% (60.90%)

-117.90% (35.04%)

-181.50% (-182.84%)

Return on Average Equity (ROAE)

-11.00% (64.74%)

-31.20% (51.02%)

-63.70% (-206.70%)

59.70% (7562.50%)

Return on Average Assets (ROAA)

-9.80% (61.57%)

-25.50% (37.96%)

-41.10% (-24.17%)

-33.10% (-1134.38%)

Return on Sales (ROS)

-19.60% (61.42%)

-50.80% (59.71%)

-126.10% (36.70%)

-199.20% (-203.91%)

Return on Invested Capital (ROIC)

-11.20% (55.38%)

-25.10% (28.90%)

-35.30% (-9.63%)

-32.20% (-216.67%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-48.42 (-69.33%)

-28.6 (-443.96%)

-5.26 (-66.84%)

-3.15

Price to Sales Ratio (P/S)

9.55 (-38.77%)

15.6 (118.06%)

7.15 (5.42%)

6.78

Price to Book Ratio (P/B)

4.93 (-45.36%)

9.02 (130.79%)

3.91 (75.52%)

2.23

Debt to Equity Ratio (D/E)

0.13 (-3.62%)

0.14 (-79.40%)

0.67 (70.05%)

0.39 (478.85%)

Earnings Per Share (EPS)

-0.71 (49.65%)

-1.41 (41.49%)

-2.41 (32.49%)

-3.57 (-492.31%)

Sales Per Share (SPS)

3.6 (39.26%)

2.58 (45.88%)

1.77 (6.88%)

1.66 (-58.12%)

Free Cash Flow Per Share (FCFPS)

-0.58 (57.24%)

-1.35 (39.16%)

-2.21 (35.34%)

-3.42 (66.37%)

Book Value Per Share (BVPS)

7.24 (55.48%)

4.65 (43.20%)

3.25 (-67.97%)

10.15 (108.74%)

Tangible Assets Book Value Per Share (TABVPS)

8.2 (54.70%)

5.3 (-2.41%)

5.43 (-61.62%)

14.14 (-47.91%)

Enterprise Value Over EBIT (EV/EBIT)

-50 (-56.25%)

-32 (-433.33%)

-6 (0.00%)

-6

Enterprise Value Over EBITDA (EV/EBITDA)

-58.06 (-65.61%)

-35.06 (-423.66%)

-6.7 (3.34%)

-6.93

Asset Turnover

0.5 (7.28%)

0.47 (54.64%)

0.3 (96.10%)

0.15 (10.79%)

Current Ratio

11.36 (40.93%)

8.06 (3.22%)

7.81 (-50.95%)

15.91 (126.52%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$22,386,000 (51.76%)

-$46,407,000 (24.22%)

-$61,243,000 (-31.29%)

-$46,648,000 (-23.61%)

Enterprise Value (EV)

$1,379,540,507 (-4.11%)

$1,438,699,873 (271.91%)

$386,837,077 (36.20%)

$284,030,544

Earnings Before Tax (EBT)

-$27,405,000 (43.60%)

-$48,588,000 (27.21%)

-$66,747,000 (-37.11%)

-$48,680,000 (-276.17%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$23,760,000 (42.10%)

-$41,037,000 (28.98%)

-$57,779,000 (-40.89%)

-$41,010,000 (-227.54%)

Invested Capital

$287,527,000 (86.40%)

$154,256,000 (-6.70%)

$165,327,000 (-17.91%)

$201,403,000 (91.13%)

Working Capital

$267,947,000 (81.65%)

$147,504,000 (25.73%)

$117,318,000 (-28.99%)

$165,218,000 (136.36%)

Tangible Asset Value

$318,563,000 (74.51%)

$182,550,000 (21.57%)

$150,164,000 (-22.08%)

$192,721,000 (91.43%)

Market Capitalization

$1,385,667,507 (-4.17%)

$1,445,939,873 (311.68%)

$351,233,077 (14.14%)

$307,731,544

Average Equity

$249,408,750 (59.87%)

$156,009,500 (48.93%)

$104,752,500 (228.47%)

-$81,540,500 (80.82%)

Average Assets

$279,424,000 (46.64%)

$190,548,250 (17.32%)

$162,411,500 (10.55%)

$146,908,500 (39.18%)

Invested Capital Average

$243,842,250 (34.90%)

$180,756,500 (3.13%)

$175,277,250 (25.40%)

$139,777,250 (37.01%)

Shares

40,304,465 (12.39%)

35,861,604 (29.36%)

27,721,632 (1.34%)

27,353,915 (3.14%)